Abstract:Background: As the number of allergic disease increases, studies to identify new treatments take on new urgency. Epigallocatechin gallate (EGCG), a major component of green tea, has been shown to possess a wide range of pharmacological properties, including anti-inflammation and anti-viral infection. In previous study, gallic acid (GA), a part of EGCG, has shown anti-allergic inflammatory effect. To improve on preliminary evidence that GA has allergy mitigating effect, we designed SG-SP1 based on GA, and aimed to assess the effects of SG-SP1 on mast cell-mediated allergic inflammation using various animal and in vitro models. Methods: For in vitro experiments, various types of IgE-stimulated mast cells (RBL-2H3: mast cell-like basophilic leukemia cells, and primary cultured peritoneal and bone marrow-derived mast cells) were used to determine the role of SG-SP1 (0.1-1 nM). Immunoglobulin (Ig) E-induced passive cutaneous anaphylaxis and ovalbumin-induced systemic anaphylaxis, standard animal models for immediate-type hypersensitivity were also used. Results: For in vitro, SG-SP1 reduced degranulation of mast cells by down-regulating intracellular calcium levels in a concentration-dependent manner. SG-SP1 decreased expression and secretion of inflammatory cytokines in activated mast cells. This suppressive effect was associated with inhibition of the phosphorylation of Lyn, Syk and Akt, and the nuclear translocation of nuclear factor-κB. Due to the strong inhibitory effect of SG-SP1 on Lyn, the known upstream signaling to FcεRI-dependent pathway, we confirmed the direct binding of SG-SP1 to FcεRI, a high affinity IgE receptor by surface plasmon resonance experiment. Oral administration of SG-SP1 hindered allergic symptoms of both anaphylaxis models evidenced by reduction of hypothermia, serum IgE, ear thickness, and tissue pigmentation. This inhibition was mediated by the reductions in serum histamine and interleukin-4. Conclusions: We determined that SG-SP1 directly interacts with FcεRI and propose SG-SP1 as a therapeutic candidate for mast cell-mediated allergic inflammatory disorders via inhibition of FcεRI signaling.

Inhibitory effects of refined bear gall on IgE-induced mast cell activation and vasular permeability

The Inhibition Of Mast Cell Activation Of Radix Paeoniae Alba Extraction Identified By Tcrp Based And Conventional Cell Function Assay Systems

Anti-allergic Activity of Grapeseed Extract (GSE) on RBL-2H3 Mast Cells

Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions

Paeoniflorin Inhibits IgE-mediated Allergic Reactions by Suppressing the Degranulation of Mast Cells Though Binding with FcϵRI Alpha Subunits.

Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways

The Anti-Allergy Effects for Active Constituents Extracted from Chinese Medicinal Herbs

Effect of Glycyrrhizae Radix Pharmacopuncture on PCA and Secretion of ${\Beta}$-Hexosaminidase and Cytokines in RBL-2H3 Cells

Ursolic Acid Attenuates Pseudo-Allergic Reactions Via Reducing MRGPRX2-mediated Mast Cell Degranulation.

Imperatorin Suppresses Anaphylactic Reaction and IgE-Mediated Allergic Responses by Inhibiting Multiple Steps of FceRI Signaling in Mast Cells: IMP Alleviates Allergic Responses in PCA

Berberine Suppresses Mast Cell-Mediated Allergic Responses Via Regulating FcɛRI-mediated and MAPK Signaling.

The Inhibitory Effect of Piperine from Fructus Piperis Extract on the Degranulation of RBL-2H3 Cells

Chemical composition-based characterization of the anti-allergic effect of Guominkang Formula on IgE-mediated mast cells activation and passive cutaneous anaphylaxis

Study of Degranulation Induced by Injective Excipients in a Rat Mast (RBL-2H3) Cell Line

Inhibitory effect of phellodendrine on C48/80-induced allergic reaction in vitro and in vivo

Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression

Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF- κ B Signaling Pathways

Studies on the Specific Degranulation of Mast Cell Sensitized by Several Allergens in Vitro

SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling

Inhibitory Effects of Bisdemethoxycurcumin on Mast Cell-Mediated Allergic Diseases

Human Lactobacillus Strains from the Intestine can Suppress IgE-Mediated Degranulation of Rat Basophilic Leukaemia (RBL-2H3) Cells